Headinvest, LLC Bristol Myers Squibb CO Transaction History

Headinvest, LLC

$470 Million
Q4 2023

A detailed history of Headinvest, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Headinvest, LLC holds 16,352 shares of BMY stock, worth $655,061. This represents 0.18% of its overall portfolio holdings.

Number of Shares

16,352

Previous 18,063 9.47%

Holding current value

$655,061

Previous $1.05 Million 19.94%

% of portfolio

0.18%

Previous 0.23%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $82,949 - $98,981	-1,711 Reduced 9.47%	16,352 $839,000
Q3 2023 Dec 11, 2023	SELL	$57.89 - $64.73 $62,521 - $69,908	-1,080 Reduced 5.64%	18,063 $1.05 Million
Q2 2023 Aug 23, 2023	SELL	$63.71 - $70.74 $623,529 - $692,332	-9,787 Reduced 33.83%	19,143 $1.22 Million
Q1 2023 May 17, 2023	SELL	$65.71 - $74.53 $113,349 - $128,564	-1,725 Reduced 5.63%	28,930 $2.01 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $181,745 - $215,212	2,654 Added 9.48%	30,655 $2.21 Million

Q3 2022 Dec 28, 2022	SELL	$0.13 - $76.84 $6 - $3,842	-50 Reduced 0.18%	28,001 $1.99 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $25,780 - $28,392	355 Added 1.28%	28,051 $2.16 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $54,901 - $65,831	893 Added 3.33%	27,696 $2.02 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $12,871 - $15,004	-240 Reduced 0.89%	26,803 $1.67 Million
Q3 2021 Nov 16, 2021	BUY	$59.17 - $69.31 $54,436 - $63,765	920 Added 3.52%	27,043 $1.6 Million
Q2 2021 Aug 30, 2021	BUY	$61.91 - $67.42 $103,203 - $112,389	1,667 Added 6.82%	26,123 $1.75 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $164,965 - $185,537	2,780 Added 12.83%	24,456 $1.54 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $154,165 - $174,698	2,670 Added 12.32%	24,346 $1.51 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $154,165 - $174,698	-2,670 Reduced 10.97%	21,676 $1.31 Million
Q3 2020 Nov 24, 2020	BUY	$57.43 - $63.64 $104,063 - $115,315	1,812 Added 9.12%	21,676 $1.31 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $127,017 - $148,496	2,317 Added 13.2%	19,864 $1.17 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $245,780 - $357,176	5,297 Added 43.24%	17,547 $978,000
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $13,224 - $19,217	285 Added 2.38%	12,250 $682,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $379,655 - $495,225	7,715 Added 181.53%	11,965 $768,000
Q3 2019 Nov 21, 2019	SELL	$42.77 - $50.71 $342,160 - $405,680	-8,000 Reduced 65.31%	4,250 $216,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $552,720 - $659,050	-12,250 Reduced 50.0%	12,250 $584,000
Q4 2018 Feb 22, 2019	BUY	$48.76 - $63.23 $577,806 - $749,275	11,850 Added 93.68%	24,500 $1.27 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $4,249 - $4,793	-77 Reduced 0.61%	12,650 $785,000
Q2 2018 Aug 09, 2018	SELL	$50.53 - $62.98 $2,425 - $3,023	-48 Reduced 0.38%	12,727 $704,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $705,563 - $814,278	12,775	12,775 $788,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headinvest, LLC with notifications on news.

Account